Cargando…
Canada's Patented Medicine Notice of Compliance regulations: balancing the scales or tipping them?
BACKGROUND: In order to comply with the provisions of the North American Free Trade Agreement, in 1993 the Canadian federal government introduced the Patented Medicine Notice of Compliance Linkage Regulations. These regulations were meant to achieve a balance between the timely entry of generic medi...
Autor principal: | Lexchin, Joel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073891/ https://www.ncbi.nlm.nih.gov/pubmed/21435247 http://dx.doi.org/10.1186/1472-6963-11-64 |
Ejemplares similares
-
Canada and access to medicines in developing countries: intellectual property rights first
por: Lexchin, Joel
Publicado: (2013) -
'Linkage' pharmaceutical evergreening in Canada and Australia
por: Faunce, Thomas A, et al.
Publicado: (2007) -
CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs
por: Lexchin, Joel, et al.
Publicado: (2014) -
Health Canada's Proposal to Accelerate New Drug Reviews
por: Lexchin, Joel
Publicado: (2020) -
Models for financing the regulation of pharmaceutical promotion
por: Lexchin, Joel
Publicado: (2012)